myocardial infarction
Generated by GPT-5-miniExpansion Funnel Raw 45 → Dedup 0 → NER 0 → Enqueued 0
| myocardial infarction | |
|---|---|
 | |
| Name | Myocardial infarction |
| Field | Cardiology |
| Symptoms | Chest pain, shortness of breath, diaphoresis, nausea |
| Complications | Heart failure, arrhythmia, cardiogenic shock |
| Onset | Acute |
| Causes | Coronary artery occlusion |
| Treatment | Reperfusion therapy, medical management |
myocardial infarction Myocardial infarction is an acute medical emergency caused by ischemic necrosis of heart muscle, typically due to coronary artery occlusion. It presents with characteristic clinical features and requires rapid diagnosis and reperfusion to reduce morbidity and mortality. Care pathways often involve coordination among emergency medical services, cardiology teams, and intensive care units.
Signs and symptoms
Patients commonly report chest pain described as pressure or crushing discomfort, often radiating to the jaw, left arm, or back; these complaints may prompt activation of systems such as the Emergency medical services and referral to centers like Mayo Clinic or Cleveland Clinic. Associated features include dyspnea, diaphoresis, nausea, syncope, and anxiety, findings monitored in settings including the Intensive Care Unit and during transfer from the Ambulance service to the Coronary care unit. Atypical presentations occur in populations seen at institutions like Mount Sinai Health System and Massachusetts General Hospital, including older adults, women, and patients with diabetes who may present with fatigue, gastrointestinal symptoms, or silent ischemia recognized by investigators at Johns Hopkins Hospital and Stanford Health Care. Clinical examination can reveal signs such as hypotension or signs of heart failure, prompting consultation with services affiliated with Harvard Medical School or Oxford University Hospitals.
Causes and risk factors
Most events are precipitated by plaque rupture or erosion of atherosclerotic lesions in the coronary arteries, processes studied by researchers at National Institutes of Health and European Society of Cardiology. Major risk factors include hypertension, hyperlipidemia, diabetes mellitus, and smoking—risk domains highlighted by public health reports from World Health Organization and Centers for Disease Control and Prevention. Family history and genetic predisposition informed by studies at Broad Institute and Wellcome Sanger Institute increase susceptibility, while lifestyle exposures like sedentary behavior and obesity are targeted in programs by American Heart Association and National Health Service (UK). Acute triggers include thrombosis, vasospasm associated with substances investigated by regulatory agencies such as the Food and Drug Administration, and embolism seen in conditions managed by services at Cleveland Clinic and Mayo Clinic.
Pathophysiology
The fundamental mechanism is interruption of coronary blood flow leading to oxygen deprivation and myocyte death, a cascade characterized in models developed at Harvard Medical School and University of Cambridge. Atherosclerotic plaque instability involves inflammatory cells and lipid cores, processes investigated by teams at Rockefeller University and Karolinska Institutet. Thrombus formation on disrupted endothelium activates coagulation pathways studied at Max Planck Society laboratories, while reperfusion injury involves oxidative stress described in research from National Heart, Lung, and Blood Institute and Dana-Farber Cancer Institute. Structural remodeling after infarction leads to scar formation and ventricular dilation, phenomena modeled in computational work at Massachusetts Institute of Technology and Imperial College London.
Diagnosis
Diagnosis integrates clinical assessment, electrocardiography, and biomarkers as recommended by guidelines from European Society of Cardiology and American College of Cardiology. The 12-lead electrocardiogram can show ST-segment elevation or new Q waves, interpretation skills taught in curricula at Johns Hopkins University and University of Oxford. Cardiac troponins I and T, developed and standardized with contributions from laboratories at National Institute for Biological Standards and Control and Laboratoire national de métrologie et d'essais, provide highly sensitive evidence of myocardial necrosis. Imaging modalities, including echocardiography performed at centers such as Royal Brompton Hospital and Karolinska University Hospital, coronary angiography in catheterization laboratories at Mount Sinai Health System and Cleveland Clinic, and cardiac MRI protocols refined at Johns Hopkins Hospital and Massachusetts General Hospital, help define extent and complications.
Management and treatment
Immediate management emphasizes oxygenation, analgesia, antiplatelet therapy, and timely reperfusion via percutaneous coronary intervention commonly performed in centers accredited by American College of Cardiology and thrombolytic therapy when PCI is unavailable, approaches endorsed by World Health Organization and European Resuscitation Council. Medications include aspirin, P2Y12 inhibitors whose development involved pharmaceutical collaborations with institutions like University of Oxford and University of California, San Francisco, beta-blockers, ACE inhibitors, and statins informed by trials from Framingham Heart Study and INTERHEART. Secondary prevention incorporates cardiac rehabilitation programs modeled on services at Royal Brompton Hospital and Cedars-Sinai Medical Center, risk factor modification supported by campaigns from American Heart Association and population initiatives by Public Health England.
Complications and prognosis
Acute complications include arrhythmias, ventricular septal rupture, papillary muscle dysfunction, and cardiogenic shock managed in specialized units at Massachusetts General Hospital and Mayo Clinic. Long-term sequelae include heart failure and increased risk of recurrent ischemic events, outcomes studied in longitudinal cohorts such as the Framingham Heart Study and registries maintained by EuroHeart. Prognosis depends on infarct size, time to reperfusion, and comorbidities; predictive models have been developed at institutions including Cleveland Clinic and Mount Sinai. Advances in systems of care highlighted by organizations like World Health Organization and American College of Cardiology continue to reduce mortality worldwide.